The goal of the study is to define and measure biological processes that contribute to the underlying pathophysiologic process of peri-partum depression to be used for identifying those at risk for developing it. This knowledge may also generate novel drug targets for peripartum depression that may be applicable to other types of depression.
This study analyses the role of inflammation and metabolites of inflammation in perinatal depression. Psychiatric assessments of depression and suicidality will be compared to blood levels of two metabolites of inflammation, quinolinic acid (QUIN) and picolinic acid (PIC), that might regulate nerve cell communication. The levels of these metabolites are regulated by kynurenine pathway enzymes. Psychiatric symptoms, inflammatory cytokines and levels of the metabolites will be measured throughout pregnancy. Additionally, the investigators are gathering placentas at delivery and determining the degree of inflammation in the tissue in the investigators' laboratory. Inflammatory biomarkers, antibody titers, and key kynurenine pathway enzymes and metabolites from pre- and post partum women, placenta, and cord blood will be measured.
Study Type
OBSERVATIONAL
Enrollment
209
Spectrum Health System
Grand Rapids, Michigan, United States
Van Andel Research Institute
Grand Rapids, Michigan, United States
Pine Rest Christian Mental Health Services
Grand Rapids, Michigan, United States
Change in activity of the enzyme aminocarboxymuconate semialdehyde decarboxylase ACMSD in blood during pregnancy
Blood levels of quinolinic acid and picolinic acid (product of ACMSD) at three timepoints during pregnancy and one time-point after pregnancy
Time frame: Up to pregnancy week 13 (1st sample), up to week 25 (second sample) and up to delivery (3rd sample) and post-partum (4th sample, within 6 months after delivery)
Activity of the enzyme aminocarboxymuconate semialdehyde decarboxylase ACMSD in placenta
Placenta levels of quinolinic acid and picolinic acid
Time frame: At delivery
Increase in depressive symptoms
Assessment of depressive symptoms by means of the Edinburgh Postnatal Depression Scale
Time frame: Up to pregnancy week 13 (1st assessment), up to week 25 (second assessment) and up to delivery (3rd assessment) and post-partum (4th assessment, within 6 months after delivery)
Suicidal symptoms
Assessment of suicidal symptoms by means of the Columbia Suicide Severity Rating Scale
Time frame: Post-partum (within 6 months after delivery).
Change in blood inflammation
Analysis of the inflammatory cytokine IL-6 in blood
Time frame: Up to pregnancy week 13 (1st sample), up to week 25 (second sample) and up to delivery (3rd sample) and post-partum (4th sample, within 6 months after delivery)
Placenta inflammation
Analysis of the expression of the inflammatory cytokine IL-6 in placental tissue
Time frame: At delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.